Skip to main content
Figure 3 | Journal of Hematology & Oncology

Figure 3

From: CBFB-MYH11 hypomethylation signature and PBX3 differential methylation revealed by targeted bisulfite sequencing in patients with acute myeloid leukemia

Figure 3

Expression of hypomethylated genes in inv(16) AML measured by TaqMan gene expression assays. Relative expression value of MN1 (A), SPARC (B), ST18 (C) and DHRS3 (D) in inv(16) AML patients versus other AML subtypes and healthy control cells; MNC - mononuclear cells; asterisks correspond to statistically significant changes of expression, ***P < 0.0001, *P < 0.05, ns - not significant.

Back to article page